Shimadzu Scientific Instruments
Ceres Nanosciences, LLLP, and Shimadzu Scientific Instruments, have developed a strategic product development and delivery relationship focused on integrating the Nanotrap® technology with Shimadzu's leading life sciences platforms. The first stage of the partnership includes the release of a breakthrouh Nanotrap® Biomarker Discovery Platform, a powerful integrated platform merging Ceres' Nanotrap, Shimadzu's MALDI line, and Nonlinear Dynamic's Progenesis analytical software.
>> See press release

SAIC-Frederick
Ceres Nanosciences, LLLP, and National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), have signed a collaboration agreement to assess Ceres' nanotechnology-based system that can isolate scant amounts of substances in body fluids, with an eye toward developing tools for diagnosing cancer at the earliest possible stage when treatments are most effective.
>> See press release

United States Anti-Doping Agency (USADA)
Ceres Nanosciences, LLLP and the United States Anti-Doping Agency are in partnership to develop a urine-based HGH test for use in anti-doping.
>> See press release